ArticleInnovations in clinical neuroscience2017
Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency.
Open access · greenAbstract read
In one paragraph
Article in Innovations in clinical neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 53 citations in OpenAlex.
- Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.Schizophrenia bulletin · 2022Trial
- Expression and experience domains of negative symptoms in relation to social functioning in patients with schizophrenia: Results from a commonality analysis.Schizophrenia research. Cognition · 2026Article
- Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study.BJPsych open · 2025Article
- Exploring the clinical utility of rhythmic digital markers for schizophrenia.PLOS digital health · 2025Article
- Predicting models for work outcomes in patients with schizophrenia and its clinical application.Scientific reports · 2025Article
- COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).EClinicalMedicine · 2025Article
- Humor processing and its relationship with clinical features in patients with first-episode schizophrenia.Schizophrenia research. Cognition · 2025Article
- Media Use and Its Associations With Paranoia in Schizophrenia and Bipolar Disorder: Ecological Momentary Assessment.JMIR mental health · 2024Article
- Immediate post performance judgements about cognitive performance in schizophrenia and bipolar disorder: associations with test performance and subjective overall judgments regarding abilities.Cognitive neuropsychiatry · 2023Article
- Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders.Schizophrenia bulletin · 2023Article
- Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients.Schizophrenia (Heidelberg, Germany) · 2023Article
- Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia.Psychiatry research. Neuroimaging · 2023Article
- Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia.Schizophrenia research · 2023Article
- A transdiagnostic approach to negative symptoms: exploring factor structure and negative symptoms in bipolar disorders.Frontiers in psychiatry · 2023Article
- Accuracy of immediate self-assessment of neurocognitive test performance: Associations with psychiatric diagnosis and longitudinal psychotic symptoms.Journal of psychiatric research · 2022Article
- Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2022Article
- Impact of clinical symptoms and diagnosis: the electronic Person-Specific Outcome Measure (ePSOM) development programme.Journal of patient-reported outcomes · 2022Article
- Daily Ecological Momentary Assessments of happy and sad moods in people with schizophrenia and bipolar disorders: What do participants who are never sad think about their activities and abilities?Schizophrenia research. Cognition · 2021Article
- Range-Adaptive Value Representation in Different Stages of Schizophrenia: A Proof of Concept Study.Schizophrenia bulletin · 2021Article
- Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms.European psychiatry : the journal of the Association of European Psychiatrists · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Anzalee KhanDr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York.
Lora LiharskaDr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York.
Philip D HarveyDr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York.
Alexandra AtkinsDr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York.
Daniel UlshenDr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York.
Richard S E KeefeDr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York.
Nathan Kline Institute for Psychiatric Research · US
Funding
A Virtual Reality Mindfulness Application for Aggression in SchizophreniaR61MH133785 · NIMH · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI ANZALEE KHAN · 2025 to 2026
$1.3MNIMH NIH HHS R61 MH133785
Abstract
PubMed holds no abstract for this paper.
Indexed as
experiential deficitsexpressive deficitsnegative symptomsPANSSPositive and Negative Syndrome ScaleSchizophrenia
Identifiers
PMID
29410935PMC
PMC5788249OpenAlex
W2921520099What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.